KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Castle Biosciences (CSTL) Current Assets: 2018-2025

Historic Current Assets for Castle Biosciences (CSTL) over the last 7 years, with Sep 2025 value amounting to $357.6 million.

  • Castle Biosciences' Current Assets rose 3.71% to $357.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $357.6 million, marking a year-over-year increase of 3.71%. This contributed to the annual value of $360.2 million for FY2024, which is 21.82% up from last year.
  • Per Castle Biosciences' latest filing, its Current Assets stood at $357.6 million for Q3 2025, which was up 2.55% from $348.7 million recorded in Q2 2025.
  • In the past 5 years, Castle Biosciences' Current Assets registered a high of $426.7 million during Q1 2021, and its lowest value of $269.1 million during Q2 2023.
  • Moreover, its 3-year median value for Current Assets was $320.4 million (2024), whereas its average is $317.5 million.
  • Per our database at Business Quant, Castle Biosciences' Current Assets surged by 266.08% in 2021 and then declined by 23.15% in 2022.
  • Over the past 5 years, Castle Biosciences' Current Assets (Quarterly) stood at $353.7 million in 2021, then decreased by 17.37% to $292.3 million in 2022, then grew by 1.15% to $295.6 million in 2023, then climbed by 21.82% to $360.2 million in 2024, then climbed by 3.71% to $357.6 million in 2025.
  • Its Current Assets was $357.6 million in Q3 2025, compared to $348.7 million in Q2 2025 and $349.4 million in Q1 2025.